C Ray Therapeutics Completes Over $100 Million Series A+ Financing, Jointly Led by SCGC and TaiLong Capital
CHENGDU,China,Nov. 18,2024-- In November 2024,C Ray Therapeutics (Chengdu) Co.,Ltd. (hereinafter referred to as "C Ray"),an innovative enterprise in the field of radiopharmaceuticals,announc